These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 24061864

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Population pharmacokinetics of total and unbound plasma cisplatin in adult patients.
    Urien S, Lokiec F.
    Br J Clin Pharmacol; 2004 Jun; 57(6):756-63. PubMed ID: 15151521
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin-based chronotherapy for advanced non-small cell lung cancer patients: a randomized controlled study and its pharmacokinetics analysis.
    Li J, Chen R, Ji M, Zou SL, Zhu LN.
    Cancer Chemother Pharmacol; 2015 Sep; 76(3):651-5. PubMed ID: 26093951
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of platinum after oral or intravenous cisplatin: a phase 1 study in 32 adult patients.
    Urien S, Brain E, Bugat R, Pivot X, Lochon I, Van ML, Vauzelle F, Lokiec F.
    Cancer Chemother Pharmacol; 2005 Jan; 55(1):55-60. PubMed ID: 15258698
    [Abstract] [Full Text] [Related]

  • 5. Population pharmacokinetics of cisplatin in adult cancer patients.
    de Jongh FE, Gallo JM, Shen M, Verweij J, Sparreboom A.
    Cancer Chemother Pharmacol; 2004 Aug; 54(2):105-12. PubMed ID: 15127229
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
    Niioka T, Uno T, Yasui-Furukori N, Takahata T, Shimizu M, Sugawara K, Tateishi T.
    Cancer Chemother Pharmacol; 2007 Apr; 59(5):575-80. PubMed ID: 16912889
    [Abstract] [Full Text] [Related]

  • 7. Population pharmacokinetic analysis of patritumab, a HER3 inhibitor, in subjects with advanced non-small cell lung cancer (NSCLC) or solid tumors.
    Yoshiba S, Jansen M, Matsushima N, Chen S, Mendell J.
    Cancer Chemother Pharmacol; 2016 May; 77(5):987-96. PubMed ID: 27017616
    [Abstract] [Full Text] [Related]

  • 8. Body-surface area-based dosing does not increase accuracy of predicting cisplatin exposure.
    de Jongh FE, Verweij J, Loos WJ, de Wit R, de Jonge MJ, Planting AS, Nooter K, Stoter G, Sparreboom A.
    J Clin Oncol; 2001 Sep 01; 19(17):3733-9. PubMed ID: 11533095
    [Abstract] [Full Text] [Related]

  • 9. [Population pharmacokinetics applied to optimising cisplatin doses in cancer patients].
    Ramón-López A, Escudero-Ortiz V, Carbonell V, Pérez-Ruixo JJ, Valenzuela B.
    Farm Hosp; 2012 Sep 01; 36(5):392-402. PubMed ID: 22402361
    [Abstract] [Full Text] [Related]

  • 10. Population pharmacokinetics and pharmacodynamics of cisplatin in patients with cancer: analysis with the NONMEM program.
    Nagai N, Ogata H, Wada Y, Tsujino D, Someya K, Ohno T, Masuhara K, Tanaka Y, Takahashi H, Nagai H, Kato K, Koshiba Y, Igarashi T, Yokoyama A, Kinameri K, Kato T, Kurita Y.
    J Clin Pharmacol; 1998 Nov 01; 38(11):1025-34. PubMed ID: 9824784
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic drug monitoring for dose individualization of Cisplatin in testicular cancer patients based upon total platinum measurement in plasma.
    Salas S, Mercier C, Ciccolini J, Pourroy B, Fanciullino R, Tranchand B, Monjanel-Mouterde S, Baciuchka-Palmaro M, Dupuis C, Yang C, Balti M, Lacarelle B, Duffaud F, Durand A, Favre R.
    Ther Drug Monit; 2006 Aug 01; 28(4):532-9. PubMed ID: 16885721
    [Abstract] [Full Text] [Related]

  • 12. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE, Würthwein G, Joachim B, Boddy AV, Krischke M, Fuhr U, Thompson PA, Jörger M, Schellens JH, Hempel G.
    Cancer Chemother Pharmacol; 2013 Mar 01; 71(3):749-63. PubMed ID: 23314734
    [Abstract] [Full Text] [Related]

  • 13. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
    Zamboni WC, Gervais AC, Egorin MJ, Schellens JH, Hamburger DR, Delauter BJ, Grim A, Zuhowski EG, Joseph E, Pluim D, Potter DM, Eiseman JL.
    Clin Cancer Res; 2002 Sep 01; 8(9):2992-9. PubMed ID: 12231546
    [Abstract] [Full Text] [Related]

  • 14. Comparison of pharmacokinetics and pharmacodynamics of docetaxel and Cisplatin in elderly and non-elderly patients: why is toxicity increased in elderly patients?
    Minami H, Ohe Y, Niho S, Goto K, Ohmatsu H, Kubota K, Kakinuma R, Nishiwaki Y, Nokihara H, Sekine I, Saijo N, Hanada K, Ogata H.
    J Clin Oncol; 2004 Jul 15; 22(14):2901-8. PubMed ID: 15254059
    [Abstract] [Full Text] [Related]

  • 15. Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
    You B, Tranchand B, Girard P, Falandry C, Ribba B, Chabaud S, Souquet PJ, Court-Fortune I, Trillet-Lenoir V, Fournel C, Tod M, Freyer G.
    Lung Cancer; 2008 Nov 15; 62(2):261-72. PubMed ID: 18442869
    [Abstract] [Full Text] [Related]

  • 16. Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.
    Laurie SA, Pfister DG, Kris MG, Tong WP, Chronowski G, Pisters KM, Heelan RT, Sirotnak FM.
    Clin Cancer Res; 2001 Mar 15; 7(3):501-9. PubMed ID: 11297240
    [Abstract] [Full Text] [Related]

  • 17. A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC).
    Wakelee HA, Middleton G, Dunlop D, Ramlau R, Leighl N, Hao D, Lopez-Anaya A, Zatloukal P, Jacobs CD.
    Cancer Chemother Pharmacol; 2012 Mar 15; 69(3):815-24. PubMed ID: 22057854
    [Abstract] [Full Text] [Related]

  • 18. Population Pharmacokinetics of Pemetrexed in Adult Non-Small Cell Lung Cancer in Indian Patients.
    Srinivasan M, Chaturvedula A, Fossler MJ, Patil A, Gota V, Prabhash K.
    J Clin Pharmacol; 2019 Sep 15; 59(9):1216-1224. PubMed ID: 30973978
    [Abstract] [Full Text] [Related]

  • 19. Population pharmacokinetic analysis of free and bound aflibercept in patients with advanced solid tumors.
    Thai HT, Veyrat-Follet C, Mentré F, Comets E.
    Cancer Chemother Pharmacol; 2013 Jul 15; 72(1):167-80. PubMed ID: 23673444
    [Abstract] [Full Text] [Related]

  • 20. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H, Mayer PR, Wajdula J, Fatenejad S.
    J Clin Pharmacol; 2004 Nov 15; 44(11):1235-43. PubMed ID: 15496641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.